Short answer
Philip Morris International (PM) filed an 8-K current report with the SEC on July 22, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Filing contains only signature and Inline XBRL cover-page information.
Philip Morris International 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Filing contains only signature and Inline XBRL cover-page information
- No fiscal-year 2026 operating results or financial metrics included in the provided 2.02 text
Item EX-99.1 · Exhibit EX-99.1
- Q2 net revenue reached $11.2B, up 10.4%, with adjusted diluted EPS up 15.2% to $2.20
- Smoke-free products generated approximately 42% of revenue, with segment revenue up 11.7% and shipments up 7.5%
- IQOS volumes grew 7.6%, while VEEV shipments surged 55.1% and ZYN expanded to 60 markets
- FDA granted MRTP authorization to 20 ZYN variants, strengthening U.S. regulatory positioning and product differentiation
- FY2026 adjusted EPS forecast remains $8.26–$8.41, while currency benefit was reduced to $0.15 from $0.20 forecast previously
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Philip Morris International 8-K filings
Get the next PM 8-K as it lands
Follow PM for push alerts, or ask the research agent what this filing means.